Search Results 251-260 of 18120 for Crohns disease

  1. Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy - Mayo Clinic

    ... Crohn's Disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

  2. Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease - Mayo Clinic

    The purpose of this study is to determine the effectiveness of RPC1063 in the initial treatment of moderate to severely active Crohn's disease. Participation ...

  3. Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD

    ... disease (IBD) symptoms. Unfortunately, about a third of individuals diagnosed with IBD do not respond to anti-TNF agents, and half of the patients who ...

  4. Digestive Diseases News - Medical Professionals - Mayo Clinic

    Five individuals with inflammatory bowel disease (IBD) and obesity experienced effective weight loss after endoscopic bariatric therapy (EBT). April 21, 2023 ...

  5. Mayo Clinic Minute: What is inflammatory bowel disease? Video Audio People often associate inflammatory bowel disease with t

    disease with the bathroom because of its symptoms, but it's a serious and chronic condition. There are two main types of IBD: Crohn's disease and ulcerative ...

  6. Mayo Clinic: Patients with Inflammatory Bowel Disease at Higher Risk for Stroke and Heart Attack

    The results of the comparison pointed to a 10-25 percent increased risk of stroke and heart attacks in patients with IBD. The increased risk was especially more ...

  7. Publications - Sunanda V. Kane, M.D. - Mayo Clinic

    J Crohns Colitis. 2023 Apr 19; 17 (4):504-512. View PubMed; Guerrero Vinsard ... Crohn's Disease: Results From the SUCCESS Consortium. Am J Gastroenterol ...

  8. A Study to Develop the Use of Ultrasound to Monitor Treatment of Crohn's Disease - Mayo Clinic

    ... Crohn's disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

  9. A Study to Develop a Patient-reported Outcome Tool for Symptomatic Small Bowel Stricturing Crohn’s Disease (CD) - Mayo Clinic

    A Study to Develop a Patient-reported Outcome Tool for Symptomatic Small Bowel Stricturing Crohn's Disease (CD) ... disease, and previous treatments or health ...

  10. A Study to Evaluate Effectiveness and Safety of Ustekinumab Re-induction Therapy in Participants With Moderate to Severely Active Crohn's Disease (POWER) - Mayo Clinic

    A Study to Evaluate Effectiveness and Safety of Ustekinumab Re-induction Therapy in Participants With Moderate to Severely Active Crohn's Disease (POWER) · Share ...